This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Sensyne Health Past Earnings Performance
Past criteria checks 0/6
Key information
-31.2%
Earnings growth rate
-20.3%
EPS growth rate
| Healthcare Services Industry Growth | 7.9% |
| Revenue growth rate | 99.6% |
| Return on equity | -104.1% |
| Net Margin | -446.1% |
| Last Earnings Update | 31 Oct 2021 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Sensyne Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Oct 21 | 8 | -35 | 21 | 19 |
| 31 Jul 21 | 8 | -31 | 19 | 18 |
| 30 Apr 21 | 9 | -28 | 17 | 16 |
| 31 Jan 21 | 7 | -27 | 15 | 15 |
| 31 Oct 20 | 4 | -26 | 13 | 13 |
| 31 Jul 20 | 3 | -24 | 12 | 12 |
| 30 Apr 20 | 2 | -22 | 11 | 11 |
| 31 Jan 20 | 1 | -20 | 9 | 11 |
| 31 Oct 19 | 0 | -19 | 8 | 10 |
| 31 Jul 19 | 0 | -19 | 8 | 9 |
| 30 Apr 19 | 0 | -19 | 7 | 8 |
| 31 Jan 19 | 0 | -16 | 7 | 6 |
| 31 Oct 18 | 0 | -14 | 7 | 5 |
| 31 Jul 18 | 0 | -11 | 6 | 3 |
| 30 Apr 18 | 0 | -7 | 5 | 2 |
Quality Earnings: DSH is currently unprofitable.
Growing Profit Margin: DSH is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DSH is unprofitable, and losses have increased over the past 5 years at a rate of 31.2% per year.
Accelerating Growth: Unable to compare DSH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DSH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (6.6%).
Return on Equity
High ROE: DSH has a negative Return on Equity (-104.15%), as it is currently unprofitable.